Showing 191 results

Filters Content type: News, Editors' picks, About HIV Topic: Weight gain & lipodystrophy

Many people put on a little weight after starting antiretroviral treatment, linked to a general improvement in health. However, some specific anti-HIV drugs may affect the structure of body fat and cause more weight gain than others. The mechanisms are different to lipodystrophy, which was a side effect of anti-HIV drugs which are now rarely used.

Liver disease

Most liver disease in people with HIV in low and middle-income countries is caused by metabolic disorders

News
20 June 2024
Health problems & ageing

Muscle loss combined with excess fat frequently seen in Italian men with HIV

News
17 June 2024
Weight gain & lipodystrophy

Switching from TAF to TDF leads to weight loss

News
23 April 2024
Weight gain & lipodystrophy

Weight gain on HIV treatment: more than a 'return to health' phenomenon?

News
28 March 2024
Women

Top 5 stories on HIV and women from CROI 2024

News
22 March 2024
Health problems & ageing

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

News
20 March 2024
HIV treatment

Top 5 HIV treatment stories from CROI 2024

News
18 March 2024
Liver disease

Semaglutide improves fatty liver disease and inflammation in people with HIV

News
13 March 2024
Menopause

Switch to an integrase inhibitor leads to greater weight during and after the menopause

News
11 March 2024
Pregnancy and vertical transmission

Greater weight gain in pregnancy reduces the risk of adverse outcomes for women with HIV

News
27 February 2024
Weight gain & lipodystrophy

FDA Denies Approval of F8 Formulation of Tesamorelin for HIV-Related Lipodystrophy

Editor's pick
Infectious Disease Advisor
29 January 2024
Exercise

Exercise Linked to Less Belly Fat in People With HIV

Editor's pick
POZ
22 December 2023
Weight gain & lipodystrophy

Lipodystrophy and HIV treatment

About HIV
December 2023
Injectable & long-acting HIV treatment

Top 10 HIV Clinical Developments of 2023

Editor's pick
TheBodyPro
1 December 2023
Weight gain & lipodystrophy

New weight-loss drugs appear safe and effective for people living with HIV

News
16 November 2023
Cardiovascular disease

More evidence that integrase inhibitors don’t raise heart disease risk

News
10 November 2023
Weight gain & lipodystrophy

GLP-1 receptor agonists promote weight loss among people with HIV One Quarter of PWH Lose More Than 5% of Weight With GLP-1 Agonists

Editor's pick
NATAP
27 October 2023
People & personal stories

From HIV to obesity – Professor Francois Venter on fighting for better health for more people

Editor's pick
Daily Maverick
25 October 2023
Weight gain & lipodystrophy

Body mass index is sufficient to predict diabetes or metabolic syndrome, Italian study finds

News
23 October 2023
Global health initiatives

EACS 2023: Conference highlights Video

October 2023
Weight gain & lipodystrophy

Weight Loss or Gain Predictors Hard to Find in INSTI-to-PI Switch Trial

Editor's pick
NATAP
19 October 2023
Weight gain & lipodystrophy

Greater weight gain in first year of HIV treatment raises risks of diabetes, metabolic syndrome and precursors of heart disease

News
2 October 2023
Drug interactions & pharmacokinetics

Antiretroviral Dose Adjustment Is Rarely Needed for Obese People With HIV, Modeling Study Suggests

Editor's pick
TheBodyPro
18 September 2023
Health problems & ageing

Top 5 stories on co-infections and co-morbidities in people with HIV from IAS 2023

News
24 August 2023